CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3).

CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3). J Clin Oncol. 2018 09 10; 36(26):2702-2709.

View in: PubMed

subject areas

Acrylamides
Adult
Aged
Aged, 80 and over
Aniline Compounds
Brain Neoplasms
Carboplatin
Carcinoma, Non-Small-Cell Lung
Cisplatin
ErbB Receptors
Female
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Pemetrexed
Protein Kinase Inhibitors
Young Adult

authors with profiles

Marina Chiara Garassino